The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it buy, with a mean price target of $66.
Southern First Bancshares Inc
SFST · USD · Market cap $574M · 315 employees
Southern First Bancshares, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-06-14
Screened 2026-06-14 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Southern First Bancshares Inc holds its Markdown at $60.68. The statistical read favours the sellers, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 1 days |
| Price at the screen | $60.68 |
| Valuation | 14.24 trailing · 9.84 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.69 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Banks - Regional
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Banks - Regional | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-06-14 screen. The gold marker is the market price at the same screen. A 10.4% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Buy. The average target sits +10% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-06-14 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 9.8xcheap for a company growing this fast |
| Trailing P/E | 14.2xreasonably valued |
| EPS, trailing | 4.26 |
| EPS, forward | 6.17 |
| Revenue growth | +26.2%strong top-line growth |
| Profit margin | 28.7%healthy profit margins |
| Return on equity | 9.8%a modest return on shareholder capital |
| Beta | 0.69steadier than the market |
| 52-week range | 34.80 - 62.38 |
| Moat | NONE |
| Market cap | $574M |
| Employees | 315 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it buy, with a mean price target of $66.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it buy, with a mean price target of $66.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $56.22 | +7.7% | · | $1,077 | +7.7% |
| 2 months | $58.41 | +3.6% | · | $1,036 | +3.6% |
| 3 months | $52.87 | +14.5% | · | $1,145 | +14.5% |
| 6 months | $55.04 | +10.0% | · | $1,100 | +10.0% |
| 1 year | $36.71 | +64.9% | · | $1,649 | +64.9% |
| 2 years | $26.12 | +131.7% | · | $2,317 | +131.7% |
| 3 years | $26.52 | +128.2% | · | $2,282 | +128.2% |
| 5 years | $53.24 | +13.7% | · | $1,137 | +13.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SFST does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.